During the corresponding time, Catheter Precision Inc recorded a revenue increase by 380.66 % year on year, sequentially revenue grew by 135.88 %. While revenue at the Catheter Precision Inc 's corporate clients
Catheter Precision Inc's Comment on Sales, Marketing and Customers
The company primarily serves hospitals performing cardiac electrophysiology lab procedures. There are an estimated 2,000 to 3,000 electrophysiology labs in the U.S. and a similar number internationally, conducting approximately 600,000 ablation procedures annually. In fiscal 2025, two individual customers accounted for approximately 28% and 12% of total revenues, with three customers collectively representing about 50% of total revenues. The company markets and sells its products domestically through direct sales personnel and internationally through a combination of direct sales and distributors. The sales team provides customer training and product demonstrations. International sales are supported by distributors and a contracted sales consultant. The company previously had a joint marketing agreement with Stereotaxis, Inc., which ended in December 2024. It intends to maintain key partnerships with distributors outside the U.S. The cardiac electrophysiology market includes major medical device companies such as Medtronic, Plc., Abbott Laboratories, Biosense-Webster (J&J), and Boston Scientific Corp. The company’s direct competitors include Abbott Laboratories.
Catheter Precision Inc’s Comment on Sales, Marketing and Customers
The company primarily serves hospitals performing cardiac electrophysiology lab procedures. There are an estimated 2,000 to 3,000 electrophysiology labs in the U.S. and a similar number internationally, conducting approximately 600,000 ablation procedures annually. In fiscal 2025, two individual customers accounted for approximately 28% and 12% of total revenues, with three customers collectively representing about 50% of total revenues. The company markets and sells its products domestically through direct sales personnel and internationally through a combination of direct sales and distributors. The sales team provides customer training and product demonstrations. International sales are supported by distributors and a contracted sales consultant. The company previously had a joint marketing agreement with Stereotaxis, Inc., which ended in December 2024. It intends to maintain key partnerships with distributors outside the U.S. The cardiac electrophysiology market includes major medical device companies such as Medtronic, Plc., Abbott Laboratories, Biosense-Webster (J&J), and Boston Scientific Corp. The company’s direct competitors include Abbott Laboratories.
Sources:
Catheter Precision Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Catheter Precision Inc’s corporate clients.
For your research, we’ve provided 9 tables on Catheter Precision Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
15.11 %